ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/12/27 | 1,114 | 1,139 | 1,101 | 1,137 | +17 | +1.5% | 441,000 |
| 2023/12/26 | 1,111 | 1,130 | 1,111 | 1,120 | +13 | +1.2% | 375,700 |
| 2023/12/25 | 1,120 | 1,125 | 1,098 | 1,107 | -15 | -1.3% | 375,200 |
| 2023/12/22 | 1,135 | 1,146 | 1,121 | 1,122 | +1 | +0.1% | 276,900 |
| 2023/12/21 | 1,132 | 1,144 | 1,117 | 1,121 | -20 | -1.8% | 343,500 |
| 2023/12/20 | 1,157 | 1,161 | 1,136 | 1,141 | -12 | -1% | 333,700 |
| 2023/12/19 | 1,145 | 1,155 | 1,136 | 1,153 | +13 | +1.1% | 271,200 |
| 2023/12/18 | 1,131 | 1,151 | 1,111 | 1,140 | -12 | -1% | 423,300 |
| 2023/12/15 | 1,174 | 1,180 | 1,142 | 1,152 | -18 | -1.5% | 418,200 |
| 2023/12/14 | 1,186 | 1,200 | 1,151 | 1,170 | ±0 | ±0% | 370,000 |
| 2023/12/13 | 1,165 | 1,184 | 1,149 | 1,170 | -1 | -0.1% | 337,400 |
| 2023/12/12 | 1,185 | 1,185 | 1,164 | 1,171 | -7 | -0.6% | 338,300 |
| 2023/12/11 | 1,183 | 1,203 | 1,168 | 1,178 | -4 | -0.3% | 411,200 |
| 2023/12/08 | 1,208 | 1,214 | 1,177 | 1,182 | -53 | -4.3% | 510,900 |
| 2023/12/07 | 1,257 | 1,269 | 1,233 | 1,235 | -23 | -1.8% | 330,800 |
| 2023/12/06 | 1,243 | 1,265 | 1,235 | 1,258 | +33 | +2.7% | 328,200 |
| 2023/12/05 | 1,250 | 1,274 | 1,225 | 1,225 | -26 | -2.1% | 310,600 |
| 2023/12/04 | 1,243 | 1,260 | 1,221 | 1,251 | -10 | -0.8% | 381,800 |
| 2023/12/01 | 1,324 | 1,325 | 1,261 | 1,261 | -63 | -4.8% | 453,400 |
| 2023/11/30 | 1,311 | 1,339 | 1,300 | 1,324 | +12 | +0.9% | 467,100 |
| 2023/11/29 | 1,317 | 1,330 | 1,305 | 1,312 | -8 | -0.6% | 241,900 |
| 2023/11/28 | 1,310 | 1,331 | 1,296 | 1,320 | +9 | +0.7% | 300,400 |
| 2023/11/27 | 1,308 | 1,338 | 1,303 | 1,311 | +4 | +0.3% | 269,000 |
| 2023/11/24 | 1,300 | 1,320 | 1,293 | 1,307 | +2 | +0.2% | 265,500 |
| 2023/11/22 | 1,261 | 1,313 | 1,256 | 1,305 | +40 | +3.2% | 382,000 |
| 2023/11/21 | 1,270 | 1,284 | 1,248 | 1,265 | -5 | -0.4% | 313,100 |
| 2023/11/20 | 1,252 | 1,288 | 1,247 | 1,270 | +22 | +1.8% | 357,200 |
| 2023/11/17 | 1,217 | 1,248 | 1,214 | 1,248 | +23 | +1.9% | 222,300 |
| 2023/11/16 | 1,262 | 1,270 | 1,222 | 1,225 | -43 | -3.4% | 388,500 |
| 2023/11/15 | 1,208 | 1,270 | 1,201 | 1,268 | +80 | +6.7% | 558,900 |
| 2023/11/14 | 1,212 | 1,212 | 1,182 | 1,188 | -24 | -2% | 342,000 |
| 2023/11/13 | 1,213 | 1,224 | 1,200 | 1,212 | -10 | -0.8% | 297,500 |
| 2023/11/10 | 1,219 | 1,236 | 1,209 | 1,222 | -21 | -1.7% | 370,300 |
| 2023/11/09 | 1,225 | 1,249 | 1,213 | 1,243 | +4 | +0.3% | 320,700 |
| 2023/11/08 | 1,225 | 1,264 | 1,225 | 1,239 | +15 | +1.2% | 467,500 |
| 2023/11/07 | 1,192 | 1,242 | 1,192 | 1,224 | +25 | +2.1% | 678,500 |
| 2023/11/06 | 1,232 | 1,233 | 1,198 | 1,199 | +8 | +0.7% | 720,200 |
| 2023/11/02 | 1,144 | 1,205 | 1,140 | 1,191 | +61 | +5.4% | 636,100 |
| 2023/11/01 | 1,156 | 1,160 | 1,125 | 1,130 | -14 | -1.2% | 581,800 |
| 2023/10/31 | 1,077 | 1,156 | 1,063 | 1,144 | +80.5 | +7.6% | 1,164,300 |
| 2023/10/30 | 1,092 | 1,106 | 1,056 | 1,063.5 | -82.5 | -7.2% | 1,245,300 |
| 2023/10/27 | 1,093 | 1,149 | 1,074 | 1,146 | +70.5 | +6.6% | 1,173,300 |
| 2023/10/26 | 1,191 | 1,197 | 1,067.5 | 1,075.5 | -55.5 | -4.9% | 2,044,100 |
| 2023/10/25 | 1,147 | 1,152.5 | 1,113.5 | 1,131 | -3.5 | -0.3% | 653,900 |
| 2023/10/24 | 1,135 | 1,146 | 1,089 | 1,134.5 | +8.5 | +0.8% | 774,200 |
| 2023/10/23 | 1,110 | 1,133 | 1,088.5 | 1,126 | +10.5 | +0.9% | 641,700 |
| 2023/10/20 | 1,119.5 | 1,125.5 | 1,093.5 | 1,115.5 | -20.5 | -1.8% | 597,600 |
| 2023/10/19 | 1,141 | 1,160 | 1,130 | 1,136 | -32 | -2.7% | 391,000 |
| 2023/10/18 | 1,191 | 1,193.5 | 1,159 | 1,168 | -27 | -2.3% | 439,000 |
| 2023/10/17 | 1,200 | 1,210 | 1,185 | 1,195 | +11 | +0.9% | 328,700 |
351～
400
件表示中 / 6969件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 57,000円 | +14.3% | - | 3.51% | 23.15倍 | 1.48倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 92,600円 | +20.3% | - | 0.00% | 164.18倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 栄研化 | 202,000円 | +4.1% | -3.1% | 2.87% | 17.59倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| あすかＨＤ | 231,100円 | +16.9% | +33.2% | 2.38% | 12.61倍 | 1.00倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ハートシード | 282,500円 | +174.2% | - | 0.00% | - | 9.65倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
市場注目の銘柄
チャート関連のコラム
